HomeORMP • NASDAQ
add
Oramed Pharmaceuticals, Inc.
$2.22
Makalipas ang Oras ng Trabaho:(1.35%)+0.030
$2.25
Sarado: Hun 6, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.15
Sakop ng araw
$2.07 - $2.25
Sakop ng taon
$1.82 - $3.09
Market cap
90.69M USD
Average na Volume
76.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.00M | — |
Gastos sa pagpapatakbo | 4.51M | 52.36% |
Net na kita | -7.64M | -597.53% |
Net profit margin | -382.10 | — |
Kita sa bawat share | — | — |
EBITDA | -4.47M | -53.82% |
Aktuwal na % ng binabayarang buwis | -8.27% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 130.64M | -26.02% |
Kabuuang asset | 147.54M | -27.55% |
Kabuuang sagutin | 7.64M | -79.84% |
Kabuuang equity | 139.89M | — |
Natitirang share | 40.85M | — |
Presyo para makapag-book | 0.62 | — |
Return on assets | -7.43% | — |
Return on capital | -7.87% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.64M | -597.53% |
Cash mula sa mga operasyon | -3.52M | -138.41% |
Cash mula sa pag-invest | 23.62M | -21.27% |
Cash mula sa financing | — | — |
Net change in cash | 20.10M | 111.07% |
Malayang cash flow | -295.50K | 80.34% |
Tungkol
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
CEO
Itinatag
2006
Website
Mga Empleyado
13
